Search Results - "Abdeen, Sanofar J"
-
1
Capillary mediated vitrification is a novel technique that enables storage of antibody critical reagents at ambient temperature: Impact on binding, structure, and laboratory sustainability
Published in Journal of pharmaceutical and biomedical analysis (15-12-2024)“…Antibodies and antibody conjugates are essential components of life science research, but their inherent instability necessitates cold storage or…”
Get full text
Journal Article -
2
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin
Published in Journal of pharmaceutical and biomedical analysis (05-08-2023)“…Efruxifermin (EFX) is a homodimeric human IgG1 Fc-FGF21 fusion protein undergoing investigation for treatment of liver fibrosis due to nonalcoholic…”
Get full text
Journal Article -
3
FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
Published in New biotechnology (25-05-2021)“…•Monobodies were generated via phage-display to the SARS-CoV-2 spike protein.•Affinities of the monobodies for the RBD are estimated between 3 and 14 nM.•The…”
Get full text
Journal Article -
4
Critical reagent inventory management system and web portal specifically optimized for supporting external clients
Published in Bioanalysis (01-06-2022)“…High-quality critical reagents are essential for the establishment of robust ligand binding assays to support regulated bioanalysis. To ensure consistency in…”
Get full text
Journal Article -
5
Peptide Inhibitors Targeting Clostridium difficile Toxins A and B
Published in ACS chemical biology (17-12-2010)“…Clostridium difficile causes severe hospital-acquired antibiotic-associated diarrhea due to the activity of two large protein toxins. Current treatments suffer…”
Get full text
Journal Article -
6
Generation of Affinity Purified Antibody Reagents for Specific Determination of Efruxifermin in Biological Matrices
Published in Journal of the Endocrine Society (03-05-2021)“…Efruxifermin (EFX) is a novel Fc-fusion analog of human fibroblast growth factor 21 (FGF21), currently in clinical development as a potential treatment for…”
Get full text
Journal Article -
7
Development of peptide inhibitors targeting Clostridium difficile toxins A/B and characterizing the regulatory role of a putative negative regulator TcdC in Clostridium difficile toxin gene expression
Published 01-01-2013“…Clostridium difficile infections cause one of the most common and vital hospitalacquired diseases often associated with broad-spectrum antibiotic usage. TcdA…”
Get full text
Dissertation -
8
Development of peptide inhibitors targeting Clostridium difficile toxins A/B and characterizing the regulatory role of a putative negative regulator TcdC in Clostridium difficile toxin gene expression
Get full text
Dissertation